European Archives - Page 608 of 1122 - European Medical Journal

EMJ Oncology 8 [Supplement 4] 2020 Feature Image

3rd Breast Cancer Virtual Masterclass Symposium: MONARCH 2, a Phase III Study of Abemaciclib or Placebo in Combination with Fulvestrant

More than 70% of patients diagnosed with metastatic breast cancer present with oestrogen-HR+ disease and are therefore candidates for endocrine…

EMJ Oncology 8 [Supplement 4] 2020 Feature Image

EMJ Oncology 8 [Supplement 4] 2020

The annual masterclass, organised by the Saudi Oncology Society (SOS), addressed the knowledge gaps in breast cancer care in Saudi Arabia…

Can Early Liver Damage Detection with a Novel Sensor Prevent Liver Failure?

FATTY liver disease is a condition experienced by one-quarter of the population in USA and, along with liver fibrosis, does not have a quick or easy…

Novel Predictive Model with Bedside Measures Predicts Hepatic Encephalopathy Risk

ACCURATE determination for the risk of and predictors for overt hepatic encephalopathy in patients with cirrhosis was measured using factors such as…

Lung Bacteria Can Defend Against Pneumonia

LACTOBACILLUS has been shown to provide a barrier against Streptococcus pneumoniae colonisation in mice infected with the influenza A virus, providing new insights on how bacteria protect against invading pathogens.

Could Targeting Endothelial Cells Diminish COVID-19 Symptoms?

TARGETING endothelial cells in patients with coronavirus disease (COVID-19) with severe lung disease may provide a novel approach to restoring normal lung function, according to a recent study from Stony Brook University, Stony Brook, New York, USA.

Talking to Karen Moyse

Karen Moyse, Founder and Managing Director, KineticFuture Leadership, discusses best practices for managing conflicting personalities.

Could This New Model Predict Cytokine Release Syndrome in Immunotherapy Patients?

While many new immunotherapies are increasing cancer survival rates, tools to predict how the immunotherapy will impact a patient’s immune system are not…

Patients with Sickle Cell Disease Identified as a Vulnerable COVID-19 Population

Hospitalisation of patients with sickle cell disease (SCD) who have coronavirus disease (COVID-19) is reported to be notably higher than the average…

Derm 8.1 feature image

Skin Toxicity Caused by Sequential Treatment with PD-1 Inhibitor and mTOR Inhibitor

Immune checkpoint inhibitors and mTOR inhibitors are known to be associated with skin toxicity…